Eric Allémann

Eric Allémann is a distinguished academic and entrepreneur in the field of pharmaceutical technology. Serving as a Co-Founder and Chief Scientific Officer at KYLYS since November 2016, Eric has also held a prominent position as a Professor of Pharmaceutical Technology and Vice-President at the Université de Genève since August 2009. Eric's previous roles include President of TwentyGreen AG from August 2016 to August 2018, Scientific Advisor at the Geneva-Lausanne School of Pharmaceutical Sciences from July 2014 to July 2018, and R&D Senior Scientist at Bracco from September 2001 to May 2009. Eric’s academic journey includes earned degrees with a Post-doctoral fellowship from Université de Sherbrooke and two PhDs from the University of Geneva.